The bill amends the Controlled Substances Act in New Mexico to allow for the use of synthetic psilocybin and drugs containing synthetic psilocybin that have been approved by the federal Food and Drug Administration (FDA). Specifically, it introduces new provisions stating that if the FDA approves synthetic psilocybin, it will be recognized for use in New Mexico. Additionally, the bill modifies the language regarding how the board administers the Controlled Substances Act, replacing the term "regulation" with "rule" in several instances, and clarifying the procedures for adding substances to the controlled substances list.

Furthermore, the bill updates the Schedule I controlled substances list to exempt FDA-approved synthetic psilocybin and drugs containing it from being classified as controlled substances. This change aims to facilitate the legal use of these substances for therapeutic purposes, aligning state law with federal approvals. The bill also maintains existing exemptions for certain substances and clarifies that the authority to control substances does not extend to distilled spirits, wine, malt beverages, tobacco, or pesticides.

Statutes affected:
introduced version: 30-31-3, 30-31-6